Impact of membrane lipid polyunsaturation on dopamine D2 receptor ligand binding and signaling.
Level 5 - mechanism / opinion, no new human data
Preclinical mechanistic study (in vitro, in silico simulations, and in vivo animal models).
PubMed 36604603 · doi:10.1038/s41380-022-01928-6
What was done
The authors investigated how membrane enrichment with the n-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) affects dopamine D2 receptor (D2R) dynamics, ligand binding, and signaling. Methods included molecular dynamics simulations to assess lipid-receptor interactions and conformational changes, in vitro cell assays to measure G protein activation and beta-arrestin recruitment, and an in vivo animal model of n-3 PUFA deficiency testing behavioral responses to D2R ligands (quinpirole and aripiprazole).
What was found
No numerical values or effect sizes are reported in the abstract. Qualitatively, DHA membrane enrichment potentiated D2R ligand binding, acting as an allosteric modulator. Simulations indicated DHA preferentially interacts with D2R and selectively enhances conformational dynamics at the second intracellular loop. In cells, membrane unsaturation spared G protein activity but potentiated beta-arrestin recruitment. In vivo, n-3 PUFA deficiency blunted behavioral responses to both quinpirole and aripiprazole.
Why it matters
This study provides a biophysical mechanism showing that membrane lipid unsaturation directly modulates D2 receptor conformation and biased downstream signaling. It offers a potential mechanistic basis for how dietary PUFA levels might alter antipsychotic drug efficacy.
Limits
The study is restricted to computational, in vitro, and animal models with no human clinical data. The abstract does not disclose sample sizes, specific animal species, quantitative statistical estimates, or specific behavioral testing paradigms.
Cited by
- supports DHA deficiency causes structural impairment of neuronal serotonin and dopamine receptors, reducing neurotransmitter binding.